To the Editor We thank Dr Urquhart and colleagues for their recent trial of low-dose amitriptyline in people with chronic low back pain.1 However, the interpretation of their findings—that amitriptyline may be an effective treatment for chronic low back pain and a possible strategy to avoid using opioid analgesics—is problematic as it is not supported by the data presented.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Lin CC, McLachlan AJ, Maher CG. Low-Dose Amitriptyline for Chronic Low Back Pain. JAMA Intern Med. 2019;179(3):450. doi:10.1001/jamainternmed.2018.8140
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: